about
Epigenetic Regulation of Oxidative Stress in Ischemic StrokeMonitoring Minimal Residual Disease in the Myeloproliferative Neoplasms: Current Applications and Emerging ApproachesSocial Media and Myeloproliferative Neoplasms (MPN): Analysis of Advanced Metrics From the First Year of a New Twitter Community: #MPNSM.Primary myelofibrosis and its targeted therapy.Investigational histone deacetylase inhibitors (HDACi) in myeloproliferative neoplasms.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Emerging drugs for the treatment of myelofibrosis.
@en
type
label
Emerging drugs for the treatment of myelofibrosis.
@en
prefLabel
Emerging drugs for the treatment of myelofibrosis.
@en
P2860
P1476
Emerging drugs for the treatment of myelofibrosis.
@en
P2093
Holly L Geyer
Ruben A Mesa
P2860
P304
P356
10.1517/14728214.2015.1061502
P407
P577
2015-07-08T00:00:00Z